These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 9374689)
1. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Friedman JE; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Kaung HL; Ernsberger P Am J Physiol; 1997 Nov; 273(5):E1014-23. PubMed ID: 9374689 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB). Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764 [TBL] [Abstract][Full Text] [Related]
3. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X. Ernsberger P; Koletsky RJ; Friedman JE Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X. Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894 [TBL] [Abstract][Full Text] [Related]
5. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study. Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795 [TBL] [Abstract][Full Text] [Related]
6. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). Ishizuka T; Ernsberger P; Liu S; Bedol D; Lehman TM; Koletsky RJ; Friedman JE J Nutr; 1998 Dec; 128(12):2299-306. PubMed ID: 9868173 [TBL] [Abstract][Full Text] [Related]
8. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Kolter T; Uphues I; Eckel J Am J Physiol; 1997 Jul; 273(1 Pt 1):E59-67. PubMed ID: 9252480 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Smith TR; Elmendorf JS; David TS; Turinsky J Am J Physiol; 1997 Jun; 272(6 Pt 1):E1071-9. PubMed ID: 9227454 [TBL] [Abstract][Full Text] [Related]
12. Development of whole-body and skeletal muscle insulin resistance after one day of hindlimb suspension. O'keefe MP; Perez FR; Kinnick TR; Tischler ME; Henriksen EJ Metabolism; 2004 Sep; 53(9):1215-22. PubMed ID: 15334387 [TBL] [Abstract][Full Text] [Related]
13. Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X. Velliquette RA; Koletsky RJ; Ernsberger P Exp Biol Med (Maywood); 2002 Mar; 227(3):164-70. PubMed ID: 11856814 [TBL] [Abstract][Full Text] [Related]
14. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Chibalin AV; Yu M; Ryder JW; Song XM; Galuska D; Krook A; Wallberg-Henriksson H; Zierath JR Proc Natl Acad Sci U S A; 2000 Jan; 97(1):38-43. PubMed ID: 10618367 [TBL] [Abstract][Full Text] [Related]
15. Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat. Sloniger JA; Saengsirisuwan V; Diehl CJ; Dokken BB; Lailerd N; Lemieux AM; Kim JS; Henriksen EJ Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1074-81. PubMed ID: 15657091 [TBL] [Abstract][Full Text] [Related]
16. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. Song XM; Kawano Y; Krook A; Ryder JW; Efendic S; Roth RA; Wallberg-Henriksson H; Zierath JR Diabetes; 1999 Mar; 48(3):664-70. PubMed ID: 10078575 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300 [TBL] [Abstract][Full Text] [Related]
18. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Nawano M; Anai M; Funaki M; Kobayashi H; Kanda A; Fukushima Y; Inukai K; Ogihara T; Sakoda H; Onishi Y; Kikuchi M; Yazaki Y; Oka Y; Asano T Metabolism; 1999 Oct; 48(10):1248-55. PubMed ID: 10535386 [TBL] [Abstract][Full Text] [Related]